Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA User Fees: Complex Generics, Transparency, Communications Are Early Negotiation Targets
Jul 11 2025
•
By
Sue Sutter
The generic drug industry shared its wish list for GDUFA IV.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from United States